clinicalomicsprowebdirectory
Facebook
Linkedin
Twitter
News
Topics
Informatics
Molecular Dx
Patient Care
Oncology
Precision Medicine
Translational Research
Magazine
Browse Issues
Subscribe
Marketplace
Translational Research
Molecular Diagnostics
Oncology/Therapeutics
Healthcare Informatics
Subscribe
Get Inside Precision Medicine Magazine
Get Inside Precision Medicine eNewsletters
Multimedia
eBooks
Webinars
Summits
Learning Labs
Podcasts
Inside Precision Medicine Live
Search
Facebook
Linkedin
Twitter
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Create an account
Privacy Policy
Create an account
Welcome! Register for an account
your email
your username
A password will be e-mailed to you.
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Inside Precision Medicine
News
News & Features
Better Heart Health Early on May Offset Risk of Pregnancy-Related Hypertension
News & Features
Five Features Underlie Immunotherapy Response
News & Features
Antibiotic Use Linked to Increased Risk of Inflammatory Bowel Disease
Informatics
33 Zeroes: Verseon Advances AI Accuracy for Novel Small Molecule Designs
News & Features
New Tool Predicts Severity of TNBC
Topics
Informatics
Molecular Dx
Patient Care
Oncology
Precision Medicine
Translational Research
Magazine
Browse Issues
Subscribe
Marketplace
Translational Research
Molecular Diagnostics
Oncology/Therapeutics
Healthcare Informatics
Subscribe
Get Inside Precision Medicine Magazine
Get Inside Precision Medicine eNewsletters
Multimedia
eBooks
Webinars
Summits
Learning Labs
Podcasts
Inside Precision Medicine Live
Inside Precision Medicine
Scorpion Therapeutics, AstraZeneca Ink Deal Focused on “Undruggable” Cancer Targets.
Transcription factor
News & Features
Scorpion Therapeutics, AstraZeneca Ink Deal Focused on “Undruggable” Cancer Targets.
Chris Anderson
-
January 13, 2022
0
News & Features
Tumor Growth Inhibited by Disrupting Chromatin Accessibility, Enhancer Addiction
Kevin Mayer
-
December 29, 2021
0
News & Features
Junk DNA Sequence a Likely Driver of Telomerase Gene Activity
Malorye Branca
-
July 26, 2021
0
News & Features
Transcription Factor Extends Reach of Tumor-Fighting CAR-T Cells
Sophia Ktori
-
July 22, 2021
0
News & Features
Promising New Cancer Drug Target: RNA-Binding Proteins
Sophia Ktori
-
July 6, 2021
0
News & Features
Promising Approach to Prostate Cancer Drug Resistance Uncovered
Malorye Branca
-
June 21, 2021
0
News & Features
Drug That Enables Consistent p53 Signaling May Improve Radiation Therapy for Cancer
Anjali A. Sarkar, PhD
-
February 17, 2021
0
News & Features
Prostate Tumor Progression Aided by Circadian Clock Gene
Sophia Ktori
-
January 15, 2021
0
News & Features
Mll1 Protein Linked to More Severe Forms of Colon Cancer
Inside Precision Medicine Staff Writer
-
December 22, 2020
0
News & Features
New Single-Cell Tech IDs Innate Immune Cells that Aid Cancer Progression
Inside Precision Medicine Staff Writer
-
August 14, 2020
0
1
2
3
4
Page 3 of 4
Related Content
Five Features Underlie Immunotherapy Response
33 Zeroes: Verseon Advances AI Accuracy for Novel Small Molecule Designs
NSD2 Protein Flips Normal Androgen-Receptor Function Leading to Prostate Cancer
Burn Rubber: Superluminal Medicines Gets $120M to Take GPCR Drugs to Clinic
Inside Precision Medicine
